MRM 20-F: SEC filing

Medirom Healthcare Technologies Inc.

Filed with the SEC on · accession 0001193125-26-467176

MRM filed a 20-F (foreign annual report) with the SEC on Nov 18, 2026. The yearly report of a foreign company listed in the US — the foreign version of a 10-K. The stock moved -2.3% by the first close after the filing.

Summary of the filing

Medirom Healthcare Technologies Inc. filed its annual report on Form 20-F for fiscal year 2025, providing comprehensive financial and operational disclosures including segment results, convertible debt, and subsequent events.

Key details

FilerMedirom Healthcare Technologies Inc.

How MRM stock reacted

Close before

$0.27

Nov 17, 2026

First close after

-2.26%

$0.26

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MRM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MRM?

Click here

Frequently asked questions

What did MRM file with the SEC on Nov 18, 2026?

MRM filed a 20-F (SEC filing). Medirom Healthcare Technologies Inc. filed its annual report on Form 20-F for fiscal year 2025, providing comprehensive financial and operational disclosures including segment results, convertible debt, and subsequent events.

How do I read a 20-F?

The yearly report of a foreign company listed in the US — the foreign version of a 10-K. Read the operating review and the risk factors first. Note the currency the numbers are reported in.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 20-F (foreign annual report): The yearly report of a foreign company listed in the US — the foreign version of a 10-K.

How did MRM stock react to this filing?

MRM closed at $0.27 before the filing and $0.26 on Nov 18, 2026 (-2.26%).

Other MRM SEC filings

Get alerts when MRM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days